Neurotoxicology and Teratology publishes only peer-reviewed original reports of systematic studies in the areas of neurotoxicology
and developmental neurotoxicology in which the primary emphasis and theoretical context are on the nervous system and/or behavior. Brief
Communications describe a new method, technique, or apparatus and results of experiments which can be reported briefly with limited
figures and tables. Invited Reviews provide a timely update on selected aspects of a scientific field undergoing rapid change
or that present special methodological or interpretive problems. Full-length review articles are also published. A limited number of
relevant theoretical articles, results of symposia, and reviews with open peer commentaries will also be published. Articles will be
published in English. All article types are peer-reviewed. Submitted papers may not be simultaneously under consideration for publication
elsewhere.
Submission of Manuscripts. It is a condition of publication that all manuscripts must be submitted in English to
Neurotoxicology and Teratology's submission and review website, http://ees.elsevier.com/ntt. Authors are requested to transmit
the text and art of the manuscript in electronic form to this address. Each manuscript must also be accompanied by a cover letter outlining
the basic findings of the paper and their significance. Minimal exceptions will be exercised. The Editor welcomes submissions by the
authors of the names and addresses of up to five individuals who could expertly review the paper, and who are not from the same institutions
as the authors. The Editor reserves the right to use these or other reviewers.
Conflict of Interest and Source of Funding.
A conflict of interest exists when an author or the author's institution has a financial or other relationship with other people or organizations
that may inappropriately influence the author's actions. All submissions to Neurotoxicology and Teratology must include disclosure
of all relationships that could be viewed as presenting a potential conflict of interest. Neurotoxicology and Teratology may
use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers
in judging the article.
Conflict of Interest Statements for Authors. At the end of the text, under a subheading "Conflict
of Interest Statement," all authors must disclose any financial, personal, or their relationships with other people or organizations
within 3 years of beginning the work submitted that could inappropriately influence the work submitted. Examples of conflicts include
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants. If there
are no conflicts of interest, authors should state that there are none. Investigators should disclose potential conflicts to participants
in clinical trials and other studies and should
state in the manuscript whether they have done so. Neurotoxicology and Teratology
may decide not to publish on the basis of a declared conflict, such as the financial interest of an author in a company (or its competitors)
that makes a product discussed in the paper. Signed copies of the Neurotoxicology and Teratology Conflict of Interest policy
form are required upon submission. The Conflict of Interest policy form can be downloaded here.
In order to minimize delays, we strongly advise that the signed copies of these statements are prepared before you submit your manuscript.
Role of the Funding Source. All sources of funding should be declared as an acknowledgment at the end of the text. Authors
must also describe the role of the study sponsor(s), if any, in a study design; in the collection, analysis, and interpretation of data;
in the writing of the report; and in the decision to submit the paper for publication. If the study sponsor(s) had no such involvement,
the authors should so state.
US National Institutes of Health (NIH) voluntary posting/''Public Access Policy''. Elsevier
facilitates author posting in connection with the voluntary posting request of the NIH (referred to as the NIH "Public Access Policy",
see http://publicaccess.nih.gov/) by submitting the peer-reviewed author's manuscript directly to PubMed Central on request from the
author, immediately after final publication. Please e-mail us at NIHauthorrequest@elsevier.com that your work
has received NIH funding
(with the NIH grant/project
number(s), as well as name and e-mail address of the
Principal Investigator(s)) and that you intend to respond
to
the NIH request. Upon such confirmation, Elsevier will
submit to PubMed Central on your behalf a version of your
manuscript that will
include peer-review comments, for
public access posting 12 months after the final publication
date. This will ensure that you will have
responded fully to
the NIH request policy. There will be no need for you to
post your manuscript directly to PubMed Central, and any
such posting is prohibited (although Elsevier will not request
that manuscripts authored and posted by US government
employees should
be taken down from PubMed Central).
Individual modifications to this general policy may apply to
some Elsevier journals and its society
publishing partners.
Language Polishing. Authors who require information about language editing and copyediting services
pre- and post-submission please visit http://www.elsevier.com/locate/languagepolishing or contact
authorsupport@elsevier.com
for more information. Please note doi:10.1016/S0892-0362(06)00024-9
Neurotoxicology and Teratology 28 (2006) 162 - 164
www.elsevier.com/locate/neutera
Elsevier neither endorses nor takes responsibility for any
products, goods or services offered by outside vendors through our services
or in any advertising. For more information please refer to our Terms & Conditions (http://www.elsevier.com/locate/termsandconditions).
Preparation of Supplementary Material
Elsevier now accepts electronic supplementary material to support and enhance your
scientific research. Supplementary files offer the author additional possibilities to publish large table sets, supporting applications,
movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be
published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect (http://www.sciencedirect.com).
In order to ensure that your submitted material is directly usable, please ensure that data is provided in one of our recommended file
formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption
for each file. The supplementary material should be submitted under ""Supplementary Material" when attaching your files at submission.
For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
STYLE OF MANUSCRIPT
General Form.(1) The title page should contain: title of paper; author(s); laboratory or
institution of origin with city, state, zip code, and country; complete address for mailing proofs, including telephone and FAX numbers,
and e-mail address. (2) References, footnotes, and legends for illustrations should be typed on separate sheets, double spaced. (3) All
dimensions and measurements must be specified in the metric system. Standard nomenclature, abbreviations and symbols, as specified by
Royal Society Conference of Editors. Metrication in Scientific Journals, Am Scient 56 (1968) 159-164, should be used throughout. (4)
Italics should not be used for the purpose of emphasis.
Title. The title should not be longer than 85 characters, including
spaces between words.
Length of Paper. The editors insist upon clear, concise statement of facts and conclusions. Fragmentation
of material into numerous short reports is discouraged. There is no page or word limitation on manuscript length.
Abstract.
Each paper submitted must be accompanied by an abstract, which should be around 200 words and must be suitable for use by abstracting
services. A list of 3-6 words or short phrases suitable for indexing terms should be typed at the bottom of the abstract page accompanying
the manuscript. These terms will be printed with the paper at the end of the abstract.
Headings. All headings should be numbered
according to the following examples:
Drugs. Proprietary (trademarked) names should
be capitalized. The chemical name should precede the trade, popular name, or abbreviation of a drug the first time it occurs.
Footnotes.
Footnotes that connect authors with their affiliations should be provided as superscript lower-case letters (a,b,c, etc.) and should
be given in alphabetical order. If senior author is not to receive reprint requests, a footnote should be given to designate to whom
requests should be sent. Text footnotes should not be used; the material should be incorporated into the text. Table footnotes: see Table
(b)
References. Literature cited should be prepared according to the Numbered/Alphabetized style of the CBE. References should
be cited by number, in brackets, within the text (only one reference to a number) and listed in alphabetical order (double spaced) on
a separate sheet at the end of the manuscript. Do not recite names of authors within the text. Journal citations in the reference
list should contain the following: (a) initials and surnames of all authors (initials precede surname); (b) title of article; (c) journal
title abbreviated as listed in the List of Journals Indexed in Index Medicus; (d) volume, year, and inclusive pages. Example:
[1]R.R. Holson, B. Pearce, Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species, Neurotoxicol
Teratol 14 (1992) 221-228.
Book references should be in the following order: author, title,
publisher, city of publication, year,
and pages. Examples:
[1]R.E. Kirk, Experimental Design: Procedures for the Behavioral Sciences, Third Edition, Brooks/Cole Publishing
Company, Pacific Grove, CA, 1995.
[2]M.G. Paule, J. Adams, Interspecies comparison of the evaluation of cognitive developmental effects
of neurotoxicants in primates, in: L.W. Chang (Ed.), Principles of Neurotoxicology, Marcel Dekker, Inc., New York, 1994, pp. 713-731.
Figures. Each figure should be in one of the following preferred formats: Tiff, JPEG, PDF, and EPS. Please refer to http://www.elsvier.com/artworkinstructions
for detailed instructions on preparing electronic artwork.
Tables.(a) Each table should bear a short descriptive title and
should also be typed on separate sheets; explanatory matter should be in footnotes, not as part of the title. (b) Table footnotes should
be indicated in the body of the table in order of their appearance with superscript, lower-case letters (a,b,c etc.). Footnotes pertaining
to statistical information should be indicated with asterisks (*P , 0.01, **P , 0.001, etc.). (c) Tables must not duplicate material
in text or illustrations. (d) Vertical rules should be omitted. (e) Short or abbreviated column heads should be used. (f) Statistical
measures of variation, S.D., S.E., etc., should be identified. (g) Analysis of Variance tables should not be submitted but significant
F's should be incorporated where appropriate within the text. The appropriate form for reporting F value is: F(11, 20)= 3.05, p ⟨⟩
0.01.
Formulas and Equations. Structural chemical formulas, process flowdiagrams, and complicated mathematical expressions
should be kept to a minimum. usually chemical formulas and flow-diagrams should be drawn in India ink for reproduction as line cuts.
All subscripts, superscripts, Greek letters, and unusual characters must be clearly identified.
Anesthesia. In describing surgical
procedures on animals, the type and dosage of the anesthetic agent should be specified. Curarizing agents are not anesthetics; if these
were used, evidence must be provided that anesthesia of suitable grade and duration was employed.
Copyright. Publications
are copyrighted for the protection of the authors and the publisher. A Transfer of Copyright Agreement will be sent to the author who
submits the manuscript. The form must be completed and returned to the publisher before the article can be published.
Proofs and
Reprints. One set of proofs of accepted manuscripts will be sent to the corresponding author. No alteration of the substance of the
text, tables or figures will be allowed at this stage. Corrected proofs should be returned to the publisher within two days of receipt.
Twenty-five reprints are provided free of charge, and additional copies (minimum 100) can be ordered at prices shown on the price list
accompanying the Reprint Order Form which will be sent with the proofs.
Elsevier will do everything possible to get your article corrected
and published as quickly and accurately as possible. Therefore, it is important to ensure that all of your corrections are sent back
to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.
US
National Institutes of Health (NIH) voluntary posting (" Public Access") policy.
Elsevier facilitates author response to the NIH
voluntary posting request (referred to as the NIH "Public Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm) by posting the peer-reviewed author's manuscript directly to PubMed Central on request from the author, 12 months after formal
publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com ) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award
number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript
that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded
fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting
is prohibited.
Author enquiries. For enquiries relating to the submission of articles, please visit the journal home page
at http://www.elsevier.com. This website also provides the facility to track accepted articles and set up e-mail alerts
to inform you of when an article's status has changed, as well as detailed artwork guidelines, copyright information, frequently asked
questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided
when an article is accepted for publication.Authors of Neurotoxicology and Teratology please note: there is no page charge
for this journal.
